Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3944]

ASCO GU 2022: What to watch out for in renal

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

ASCO GU 2022: What to watch out for in renal ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

Maintenance PARP inhibition following chemotherapy for metastatic urothelial...

Dr Simon Crabb - University of Southampton, Southampton, UK

Maintenance PARP inhibition following chemotherapy for metastatic urothelial carcinoma ( Dr Simon Crabb - University of Southampton, Southampton, UK )

First randomized trial on adjuvant mitotane in adrenocortical carcinoma...

Prof Alfredo Berruti - University Of Brescia, Brescia, Italy

First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: The Adjuvo study. ( Prof Alfredo Berruti - University Of Brescia, Brescia, Italy )

Durvalumab with olapirib shows no PFS improvement for platinum-ineligible...

Prof Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA

Durvalumab with olapirib shows no PFS improvement for platinum-ineligible bladder cancer ( Prof Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Eye metastasis in breast cancer: Case report and review of literature

Dr Ereny Samwel Poles Saad - Assiut University, Asyut, Egypt

Eye metastasis in breast cancer: Case report and review of literature ( Dr Ereny Samwel Poles Saad - Assiut University, Asyut, Egypt )

Update on the new EUSOMA quality indicators for breast cancer

Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal

Update on the new EUSOMA quality indicators for breast cancer ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )

The optimal approach after neoadjuvant treatment: The Lucerne toolbox

Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal

The optimal approach after neoadjuvant treatment: The Lucerne toolbox ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )

The global impact of the FDA's changing approval standards

Dr Bishal Gyawali - Queen's University, Kingston, Canada

The global impact of the FDA's changing approval standards ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

Tumour agnostic treatments in GI cancer

Dr Nicola Normanno and Dr Katja Schmitz

Tumour agnostic treatments in GI cancer ( Dr Nicola Normanno and Dr Katja Schmitz )

ecancer-AORTIC special issue on cancer research training in Africa

Dr Solomon Rotimi - Covenant University, Ota, Nigeria

ecancer-AORTIC special issue on cancer research training in Africa ( Dr Solomon Rotimi - Covenant University, Ota, Nigeria )

OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO

Dr Don Dizon, Dr Allison Betof Warner, Dr Giancarlo Pruneri, Dr Pierfrancesco...

OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO ( Dr Don Dizon, Dr Allison Betof Warner, Dr Giancarlo Pruneri, Dr Pierfrancesco Franco & Dr Kathleen Schemeler )

More from ecancer